Pimentel FF, Tiezzi DG, Andrade JM de, Gonçalves J, Cardoso ACF, Castilho VC, et al. SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES. MAST [Internet]. 2021 Oct. 14 [cited 2024 Sep. 19];31:9. Available from: https://revistamastology.emnuvens.com.br/revista/article/view/981